These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27406814)

  • 21. Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity.
    Bos MM; Noordam R; Bennett K; Beekman M; Mook-Kanamori DO; Willems van Dijk K; Slagboom PE; Lundstedt T; Surowiec I; van Heemst D
    Metabolomics; 2020 Mar; 16(3):35. PubMed ID: 32124065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
    Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
    Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
    Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts.
    Nogal A; Tettamanzi F; Dong Q; Louca P; Visconti A; Christiansen C; Breuninger T; Linseisen J; Grallert H; Wawro N; Asnicar F; Wong K; Baleanu AF; Michelotti GA; Segata N; Falchi M; Peters A; Franks PW; Bagnardi V; Spector TD; Bell JT; Gieger C; Valdes AM; Menni C
    Diabetes; 2023 Dec; 72(12):1870-1880. PubMed ID: 37699401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of General Adiposity and Central Body Fat Distribution on the Circulating Metabolome: A Multicohort Nontargeted Metabolomics Observational and Mendelian Randomization Study.
    Ahmad S; Hammar U; Kennedy B; Salihovic S; Ganna A; Lind L; Sundström J; Ärnlöv J; Berne C; Risérus U; Magnusson PKE; Larsson SC; Fall T
    Diabetes; 2022 Feb; 71(2):329-339. PubMed ID: 34785567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
    Menni C; Fauman E; Erte I; Perry JR; Kastenmüller G; Shin SY; Petersen AK; Hyde C; Psatha M; Ward KJ; Yuan W; Milburn M; Palmer CN; Frayling TM; Trimmer J; Bell JT; Gieger C; Mohney RP; Brosnan MJ; Suhre K; Soranzo N; Spector TD
    Diabetes; 2013 Dec; 62(12):4270-6. PubMed ID: 23884885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
    Ottosson F; Smith E; Gallo W; Fernandez C; Melander O
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4921-4930. PubMed ID: 31502646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.
    Guasch-Ferré M; Hruby A; Toledo E; Clish CB; Martínez-González MA; Salas-Salvadó J; Hu FB
    Diabetes Care; 2016 May; 39(5):833-46. PubMed ID: 27208380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin.
    Nunez DJ; Yao X; Lin J; Walker A; Zuo P; Webster L; Krug-Gourley S; Zamek-Gliszczynski MJ; Gillmor DS; Johnson SL
    Diabetes Obes Metab; 2016 Jul; 18(7):654-62. PubMed ID: 26939572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
    Sharma S; Dong Q; Haid M; Adam J; Bizzotto R; Fernandez-Tajes JJ; Jones AG; Tura A; Artati A; Prehn C; Kastenmüller G; Koivula RW; Franks PW; Walker M; Forgie IM; Giordano G; Pavo I; Ruetten H; Dermitzakis M; McCarthy MI; Pedersen O; Schwenk JM; Tsirigos KD; De Masi F; Brunak S; Viñuela A; Mari A; McDonald TJ; Kokkola T; Adamski J; Pearson ER; Grallert H
    Diabetologia; 2024 Sep; ():. PubMed ID: 39349772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans.
    Liu C; Li H; Qi L; Loos RJ; Qi Q; Lu L; Gan W; Lin X
    PLoS One; 2011; 6(6):e21464. PubMed ID: 21747906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis.
    Bonnefond A; Yengo L; Le May C; Fumeron F; Marre M; Balkau B; Charpentier G; Franc S; Froguel P; Cariou B;
    Diabetologia; 2015 Sep; 58(9):2051-5. PubMed ID: 26049403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
    Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between serum bile acid profiles and gestational diabetes mellitus: A targeted metabolomics study.
    Gao J; Xu B; Zhang X; Cui Y; Deng L; Shi Z; Shao Y; Ding M
    Clin Chim Acta; 2016 Aug; 459():63-72. PubMed ID: 27246871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose.
    Hwang YC; Ahn HY; Park SW; Park CY
    Eur J Endocrinol; 2014 Jul; 171(1):137-42. PubMed ID: 24760540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
    Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H
    Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study.
    Arnlöv J; Zethelius B; Risérus U; Basu S; Berne C; Vessby B; Alfthan G; Helmersson J;
    Diabetologia; 2009 Jan; 52(1):97-105. PubMed ID: 18985315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.